Clinical Trials in New York

Showing 9161-9180 of 19,464 trials

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

NCT04001413

Combination immune checkpoint inhibitor and DNA vaccine will result in clearance of HPV DNA biomarkers (oral and/or plasma) for patients with persistent HPV-16 E6/E7 DNA (HPV biomarker) after treatment with curative intent.

HPV Positive Oropharyngeal Squamous Cell CarcinomaOropharynx CancerHPV-Related Carcinoma

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsStarted Sep 2019

Baltimore, Maryland, United States • New York, New York, United States • New York, New York, United States +1 more locations

WITHDRAWNPhase 4< 1 mile

Evolocumab In Advanced Chronic Kidney Disease Trial

NCT04510844

110 individuals with stage 4-5 Chronic Kidney Disease (CKD) will be randomized to 1-year of blinded Evolocumab or placebo. Subjects will undergo evaluation of circulating lipids at baseline and end of study. A substudy including 50 subjects will assess myocardial rest and stress positron emission tomography (PET) at baseline and at 1-year.

Chronic Kidney DiseasesHigh Cholesterol

NYU Langone HealthStarted Mar 2021

Mineola, New York, United States • New York, New York, United States

Therapy for High-Risk HPV 16-Positive Oropharynx Cancer Patients

Evolocumab In Advanced Chronic Kidney Disease Trial

Find Trials by Condition in New York

Impact of Telehealth on Engagement in Psychotherapy and/or Medication Treatment

PTH(1-34) and Pelvic Fracture Healing - a Randomized Controlled Trial

A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy

Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms

Phase I/II Study of CK-101 in NSCLC Patients and Other Advanced Solid Tumors

Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab

Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1

Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma

Trial of 4-Hydroxytamoxifen (4-OHT) Gel in Women Aimed at Reducing Dense Breast Tissue

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Efficacy and Safety of Orally Administered DS102 in Patients With Acute Alcoholic Hepatitis

A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects

Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer

Prone Positioning Short-term Effects on Tissue Oxygen Saturation in Critical COVID-19 Patients